227 related articles for article (PubMed ID: 29913454)
1. RA190, a Proteasome Subunit ADRM1 Inhibitor, Suppresses Intrahepatic Cholangiocarcinoma by Inducing NF-KB-Mediated Cell Apoptosis.
Yu GY; Wang X; Zheng SS; Gao XM; Jia QA; Zhu WW; Lu L; Jia HL; Chen JH; Dong QZ; Lu M; Qin LX
Cell Physiol Biochem; 2018; 47(3):1152-1166. PubMed ID: 29913454
[TBL] [Abstract][Full Text] [Related]
2. Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma.
Jiang RT; Yemelyanova A; Xing D; Anchoori RK; Hamazaki J; Murata S; Seidman JD; Wang TL; Roden RBS
J Ovarian Res; 2017 Aug; 10(1):53. PubMed ID: 28784174
[TBL] [Abstract][Full Text] [Related]
3. ADRM1 as a therapeutic target in hepatocellular carcinoma.
Liang YC; Wang JL; Wang HT; Liu H; Zhang HL; Liang YX
Kaohsiung J Med Sci; 2021 Jan; 37(1):47-54. PubMed ID: 32916039
[TBL] [Abstract][Full Text] [Related]
4. Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling.
Soong RS; Anchoori RK; Roden RBS; Cho RL; Chen YC; Tseng SC; Huang YL; Liao PC; Shyu YC
BMC Cancer; 2020 May; 20(1):386. PubMed ID: 32375699
[TBL] [Abstract][Full Text] [Related]
5. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
6. Perturbation of proteasome function by bortezomib leading to ER stress-induced apoptotic cell death in cholangiocarcinoma.
Vaeteewoottacharn K; Kariya R; Matsuda K; Taura M; Wongkham C; Wongkham S; Okada S
J Cancer Res Clin Oncol; 2013 Sep; 139(9):1551-62. PubMed ID: 23877657
[TBL] [Abstract][Full Text] [Related]
7. TAZ regulates cell proliferation and sensitivity to vitamin D3 in intrahepatic cholangiocarcinoma.
Xiao H; Tong R; Yang B; Lv Z; Du C; Peng C; Ding C; Cheng S; Zhou L; Xie H; Wu J; Zheng S
Cancer Lett; 2016 Oct; 381(2):370-9. PubMed ID: 27554639
[TBL] [Abstract][Full Text] [Related]
8. A possible connection between adhesion regulating molecule 1 overexpression and nuclear factor kappa B activity in hepatocarcinogenesis.
Yang X; Miao X; Wen Y; Hu J; Dai W; Yin B
Oncol Rep; 2012 Jul; 28(1):283-90. PubMed ID: 22576803
[TBL] [Abstract][Full Text] [Related]
9. Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma.
Peng H; Zhang Q; Li J; Zhang N; Hua Y; Xu L; Deng Y; Lai J; Peng Z; Peng B; Chen M; Peng S; Kuang M
Oncotarget; 2016 Mar; 7(13):17220-9. PubMed ID: 26967384
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance and therapeutic potential of hedgehog signaling in intrahepatic cholangiocellular carcinoma.
Tang L; Tan YX; Jiang BG; Pan YF; Li SX; Yang GZ; Wang M; Wang Q; Zhang J; Zhou WP; Dong LW; Wang HY
Clin Cancer Res; 2013 Apr; 19(8):2014-24. PubMed ID: 23493353
[TBL] [Abstract][Full Text] [Related]
11. Diethyldithiocarbamate suppresses an NF-kappaB dependent metastatic pathway in cholangiocarcinoma cells.
Srikoon P; Kariya R; Kudo E; Goto H; Vaeteewoottacharn K; Taura M; Wongkham S; Okada S
Asian Pac J Cancer Prev; 2013; 14(7):4441-6. PubMed ID: 23992017
[TBL] [Abstract][Full Text] [Related]
12. TLR2 promotes human intrahepatic cholangiocarcinoma cell migration and invasion by modulating NF-κB pathway-mediated inflammatory responses.
Liu B; Yan S; Jia Y; Ma J; Wu S; Xu Y; Shang M; Mao A
FEBS J; 2016 Oct; 283(20):3839-3850. PubMed ID: 27616304
[TBL] [Abstract][Full Text] [Related]
13. EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma.
Yin DL; Liang YJ; Zheng TS; Song RP; Wang JB; Sun BS; Pan SH; Qu LD; Liu JR; Jiang HC; Liu LX
Sci Rep; 2016 Aug; 6():32167. PubMed ID: 27571770
[TBL] [Abstract][Full Text] [Related]
14. Targeting proteasome ubiquitin receptor Rpn13 in multiple myeloma.
Song Y; Ray A; Li S; Das DS; Tai YT; Carrasco RD; Chauhan D; Anderson KC
Leukemia; 2016 Sep; 30(9):1877-86. PubMed ID: 27118409
[TBL] [Abstract][Full Text] [Related]
15. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
[TBL] [Abstract][Full Text] [Related]
16. FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition.
Lv B; Ma L; Tang W; Huang P; Yang B; Wang L; Chen S; Gao Q; Zhang S; Xia J
Cell Physiol Biochem; 2018; 48(1):158-172. PubMed ID: 30001540
[TBL] [Abstract][Full Text] [Related]
17. Mycoepoxydiene induces apoptosis and inhibits TPA-induced invasion in human cholangiocarcinoma cells via blocking NF-κB pathway.
Li W; Li M; Su X; Qin L; Miao M; Yu C; Shen Y; Luo Q; Chen Q
Biochimie; 2014 Jun; 101():183-91. PubMed ID: 24486723
[TBL] [Abstract][Full Text] [Related]
18. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
[TBL] [Abstract][Full Text] [Related]
19. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of Adhesion-Regulating Molecule 1 Inhibits Proliferation in HL60 Cells.
Zheng X; Guo Y; Chen Y; Chen M; Lin Z; Wu Y; Chen Y
Acta Haematol; 2015; 134(2):88-100. PubMed ID: 25896055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
